Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2017, Article ID 3083267, 8 pages
https://doi.org/10.1155/2017/3083267
Research Article

Clinical Significance of Preoperative Albumin and Globulin Ratio in Patients with Gastric Cancer Undergoing Treatment

1Department of Clinical Laboratory, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, 651 Dong Feng Road East, Guangzhou, Guangdong Province 510060, China
2Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, 651 Dong Feng Road East, Guangzhou, Guangdong Province 510060, China
3Department of Experimental Research, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, 651 Dong Feng Road East, Guangzhou, Guangdong Province 510060, China
4Guangdong Medical University, 1 Xin Cheng Road, Songshan Hu, Dongguan, Guangdong Province 523808, China

Correspondence should be addressed to Shu-qin Dai; nc.gro.ccusys@qhsiad and Wan-li Liu; moc.621@621ilnawuil

Received 13 December 2016; Revised 8 March 2017; Accepted 13 March 2017; Published 23 March 2017

Academic Editor: Sabine Rohrmann

Copyright © 2017 Min-jie Mao et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Ferlay, I. Soerjomataram, R. Dikshit et al., “Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012,” International Journal of Cancer, vol. 136, no. 5, pp. E359–E386, 2015. View at Publisher · View at Google Scholar · View at Scopus
  2. J. R. Jass, L. H. Sobin, and H. Watanabe, “The World Health Organization's histologic classification of gastrointestinal tumors. A commentary on the second edition,” Cancer, vol. 66, no. 10, pp. 2162–2167, 1990. View at Publisher · View at Google Scholar · View at Scopus
  3. T. Waddell, M. Verheij, W. Allum, D. Cunningham, A. Cervantes, and D. Arnold, “Gastric cancer: ESMO-ESSO-ESTRO clinical practice guidelines for diagnosis, treatment and follow-up,” European Journal of Surgical Oncology, vol. 40, no. 5, pp. 584–591, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. G. Tomasello, M. Ghidini, W. Liguigli, M. Ratti, L. Toppo, and R. Passalacqua, “Targeted therapies in gastric cancer treatment: where we are and where we are going,” Investigational New Drugs, vol. 34, no. 3, pp. 378–393, 2016. View at Publisher · View at Google Scholar · View at Scopus
  5. H. Jung, H. H. Lee, K. Y. Song, H. M. Jeon, and C. H. Park, “Validation of the seventh edition of the American Joint Committee on Cancer TNM staging system for gastric cancer,” Cancer, vol. 117, no. 11, pp. 2371–2378, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. S. G. Thrumurthy, M. A. Chaudry, I. Chau, and W. Allum, “Does surgery have a role in managing incurable gastric cancer?” Nature Reviews Clinical Oncology, vol. 12, no. 11, pp. 676–682, 2015. View at Publisher · View at Google Scholar · View at Scopus
  7. L. M. Coussens and Z. Werb, “Inflammation and cancer,” Nature, vol. 420, no. 6917, pp. 860–867, 2002. View at Publisher · View at Google Scholar · View at Scopus
  8. S. I. Grivennikov, F. R. Greten, and M. Karin, “Immunity, inflammation, and cancer,” Cell, vol. 140, no. 6, pp. 883–899, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. I. R. Cho, J. C. Park, C. H. Park et al., “Pre-treatment neutrophil to lymphocyte ratio as a prognostic marker to predict chemotherapeutic response and survival outcomes in metastatic advanced gastric cancer,” Gastric Cancer, vol. 17, no. 4, pp. 703–710, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Cetinkunar, H. Guzel, I. E. Gokce et al., “High levels of platelet/lymphocyte ratio are associated with metastatic gastric cancer,” Journal of B.U.ON., vol. 20, no. 1, pp. 78–83, 2015. View at Google Scholar · View at Scopus
  11. V. Arroyo, R. García-Martinez, and X. Salvatella, “Human serum albumin, systemic inflammation, and cirrhosis,” Journal of Hepatology, vol. 61, no. 2, pp. 396–407, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. Q. Li, X. Meng, L. Liang et al., “High preoperative serum globulin in rectal cancer treated with neoadjunctive chemoradiation therapy is a risk factor for poor outcome,” American Journal of Cancer Research, vol. 9, pp. 2856–2864, 2015. View at Google Scholar
  13. A. C. Kibrick and A. B. Clements, “A comparative study of the serum albumin-globulin ratio, the cephalin-cholesterol flocculation, and the thymol turbidity tests for liver function,” The Journal of Laboratory and Clinical Medicine, vol. 33, no. 6, pp. 662–671, 1948. View at Google Scholar · View at Scopus
  14. M. Shibutani, K. Maeda, H. Nagahara et al., “The pretreatment albumin to globulin ratio predicts chemotherapeutic outcomes in patients with unresectable metastatic colorectal cancer,” BMC Cancer, vol. 15, no. 1, article 347, 2015. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Park, S. Park, S.-H. Lee et al., “Pretreatment albumin-to-globulin ratio as a predictive marker for tyrosine kinase inhibitor in non-small cell lung cancer,” Cancer Biomarkers, vol. 16, no. 3, pp. 425–433, 2016. View at Publisher · View at Google Scholar · View at Scopus
  16. F. Zhang, P. Sun, Z.-Q. Wang et al., “Low preoperative albumin-globulin score predicts favorable survival in esophageal squamous cell carcinoma,” Oncotarget, vol. 7, no. 21, pp. 30550–30560, 2016. View at Publisher · View at Google Scholar · View at Scopus
  17. B. N. Azab, V. R. Bhatt, S. Vonfrolio et al., “Value of the pretreatment albumin to globulin ratio in predicting long-term mortality in breast cancer patients,” American Journal of Surgery, vol. 206, no. 5, pp. 764–770, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. J. Budczies, F. Klauschen, B. V. Sinn et al., “Cutoff Finder: a comprehensive and straightforward web application enabling rapid biomarker cutoff optimization,” PLoS ONE, vol. 7, no. 12, Article ID e51862, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. J. Chen, Y. Zhou, Y. Xu, H.-Y. Zhu, and Y.-Q. Shi, “Low pretreatment serum globulin may predict favorable prognosis for gastric cancer patients,” Tumor Biology, vol. 37, no. 3, pp. 3905–3911, 2016. View at Publisher · View at Google Scholar · View at Scopus
  20. Y. Gao and D. Huang, “The value of the systematic inflammation-based Glasgow Prognostic Score in patients with gastric cancer: a literature review,” Journal of Cancer Research and Therapeutics, vol. 10, no. 4, pp. 799–804, 2014. View at Publisher · View at Google Scholar · View at Scopus
  21. Q.-X. Pan, Z.-J. Su, J.-H. Zhang, C.-R. Wang, and S.-Y. Ke, “A comparison of the prognostic value of preoperative inflammation-based scores and TNM stage in patients with gastric cancer,” OncoTargets and Therapy, vol. 8, pp. 1375–1385, 2015. View at Publisher · View at Google Scholar · View at Scopus
  22. D. F. Quail and J. A. Joyce, “Microenvironmental regulation of tumor progression and metastasis,” Nature Medicine, vol. 19, no. 11, pp. 1423–1437, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. S. B. Coffelt and K. E. De Visser, “Cancer: inflammation lights the way to metastasis,” Nature, vol. 507, no. 7490, pp. 48–49, 2014. View at Publisher · View at Google Scholar · View at Scopus
  24. F. Chalmin, G. Mignot, and F. Ghiringhelli, “Myeloid-derived suppressor cells: a key player in cancer,” Médecine/Sciences, vol. 26, no. 6-7, pp. 576–579, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. A. Rojas, F. Delgado-López, and I. Gonzalez, “Tumor-associated macrophages in gastric cancer: more than bystanders in tumor microenvironment,” Gastric Cancer, vol. 20, no. 1, pp. 215–216, 2017. View at Publisher · View at Google Scholar · View at Scopus
  26. E. Pikarsky, R. M. Porat, I. Stein et al., “NF-κB functions as a tumour promoter in inflammation-associated cancer,” Nature, vol. 431, no. 7007, pp. 461–466, 2004. View at Publisher · View at Google Scholar · View at Scopus
  27. D. Q. Wang, X. P. Ding, S. Yin, and Y. D. Mao, “Role of the IL-11/STAT3 signaling pathway in human chronic atrophic gastritis and gastric cancer,” Genetics and Molecular Research, vol. 15, no. 2, Article ID gmr.15027358, 2016. View at Publisher · View at Google Scholar · View at Scopus
  28. C. Pfensig, A. Dominik, L. Borufka, M. Hinz, J. Stange, and M. Eggert, “A new application for albumin dialysis in extracorporeal organ support: characterization of a putative interaction between human albumin and proinflammatory cytokines IL-6 and TNFα,” Artificial Organs, vol. 40, no. 4, pp. 397–402, 2016. View at Publisher · View at Google Scholar · View at Scopus
  29. K. Yamashita, H. Ushiku, N. Katada et al., “Reduced preoperative serum albumin and absence of peritoneal dissemination may be predictive factors for long-term survival with advanced gastric cancer with positive cytology test,” European Journal of Surgical Oncology, vol. 41, no. 10, pp. 1324–1332, 2015. View at Publisher · View at Google Scholar · View at Scopus
  30. T. Fujii, T. Sutoh, H. Morita et al., “Serum albumin is superior to prealbumin for predicting short-term recurrence in patients with operable colorectal cancer,” Nutrition and Cancer, vol. 64, no. 8, pp. 1169–1173, 2012. View at Publisher · View at Google Scholar · View at Scopus
  31. O. Arrieta, R. M. Michel Ortega, G. Villanueva-Rodríguez et al., “Association of nutritional status and serum albumin levels with development of toxicity in patients with advanced non-small cell lung cancer treated with paclitaxel-cisplatin chemotherapy: a prospective study,” BMC Cancer, vol. 10, article 50, 2010. View at Publisher · View at Google Scholar · View at Scopus
  32. X. Liu, Q. H. Meng, Y. Ye, M. A. T. Hildebrandt, J. Gu, and X. Wu, “Prognostic significance of pretreatment serum levels of albumin, LDH and total bilirubin in patients with nonmetastatic breast cancer,” Carcinogenesis, vol. 36, no. 2, pp. 243–248, 2015. View at Publisher · View at Google Scholar · View at Scopus
  33. M. Ballow, “Mechanisms of action of intravenous immune serum globulin in autoimmune and inflammatory diseases,” Journal of Allergy and Clinical Immunology, vol. 100, no. 2, pp. 151–157, 1997. View at Publisher · View at Google Scholar · View at Scopus
  34. L. Adly, D. Hill, M. E. Sherman et al., “Serum concentrations of estrogens, sex hormone-binding globulin, and androgens and risk of breast cancer in postmenopausal women,” International Journal of Cancer, vol. 119, no. 10, pp. 2402–2407, 2006. View at Publisher · View at Google Scholar · View at Scopus
  35. N. Sawada, M. Iwasaki, M. Inoue et al., “Plasma testosterone and sex hormone-binding globulin concentrations and the risk of prostate cancer among Japanese men: a nested case-control study,” Cancer Science, vol. 101, no. 12, pp. 2652–2657, 2010. View at Publisher · View at Google Scholar · View at Scopus